tiprankstipranks
Trending News
More News >
Avecho Biotechnology Limited (AU:AVE)
ASX:AVE
Australian Market

Avecho Biotechnology Limited (AVE) Financial Statements

Compare
9 Followers

Avecho Biotechnology Limited Financial Overview

Avecho Biotechnology Limited's market cap is currently AU$36.73M. The company's EPS TTM is AU$0; its P/E ratio is -7.14; Avecho Biotechnology Limited is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 1.24MAU$ 1.13MAU$ 473.55KAU$ 1.13MAU$ 793.60K
Gross ProfitAU$ 751.29KAU$ 671.93KAU$ -43.80KAU$ 793.12KAU$ 507.94K
Operating IncomeAU$ -6.00MAU$ -4.96MAU$ -4.59MAU$ -3.06MAU$ -4.55M
EBITDAAU$ -5.87MAU$ -2.92MAU$ -3.24MAU$ -2.11MAU$ -2.98M
Net IncomeAU$ -4.42MAU$ -3.12MAU$ -3.44MAU$ -2.34MAU$ -3.42M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 4.66MAU$ 2.37MAU$ 5.50MAU$ 1.47MAU$ 3.26M
Total AssetsAU$ 7.11MAU$ 5.00MAU$ 7.32MAU$ 3.35MAU$ 5.25M
Total DebtAU$ 14.47KAU$ 1.08MAU$ 175.15KAU$ 246.07KAU$ 93.91K
Net DebtAU$ -4.65MAU$ -1.30MAU$ -5.33MAU$ -1.22MAU$ -3.17M
Total LiabilitiesAU$ 5.55MAU$ 1.73MAU$ 941.54KAU$ 920.66KAU$ 709.36K
Stockholders' EquityAU$ 1.56MAU$ 3.27MAU$ 6.38MAU$ 2.42MAU$ 4.54M
Cash Flow
Free Cash FlowAU$ 1.10MAU$ -3.97MAU$ -3.18MAU$ -1.72MAU$ -3.30M
Operating Cash FlowAU$ 1.10MAU$ -3.97MAU$ -3.18MAU$ -1.67MAU$ -3.10M
Investing Cash FlowAU$ 0.00AU$ -15.73KAU$ 0.00AU$ -53.12KAU$ -202.82K
Financing Cash FlowAU$ 1.19MAU$ 854.59KAU$ 7.22MAU$ -78.22KAU$ 4.69M
Currency in AUD

Avecho Biotechnology Limited Earnings and Revenue History

Avecho Biotechnology Limited Debt to Assets

Avecho Biotechnology Limited Cash Flow

Avecho Biotechnology Limited Forecast EPS vs Actual EPS